| Dr Sucharita R Kher, MD | |
|
800 Washington St, Box 369, Boston, MA 02111-1552 | |
| (617) 636-6366 | |
| (617) 636-6361 |
| Full Name | Dr Sucharita R Kher |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 23 Years |
| Location | 800 Washington St, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588637755 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 227716 (Massachusetts) | Primary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 227716 (Massachusetts) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tufts Medical Center | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pratt Medical Group Inc | 3375515661 | 265 |
News Archive
Children whose parents and families are under ongoing stress have more fevers with illness than other children. Published this month in the Archives of Pediatric and Adolescent Medicine, the study also shows the unanticipated conclusion that children's natural killer cell function, part of the body's innate immune system, increases under chronic stress, unlike adults, whose function is decreased.
Associate Professor Emeritus of Psychiatry and Pediatrics (OHSU, Portland, Oregon) is seeking roughly 50-100 volunteer families to participate in a vitamin D study. The goal of the study is to find out whether giving Vitamin D to the pregnant mother, who already has had at least one previous child with autism, can prevent the recurrence of autism in the newborn sibling.
Prior Scientific's Z-Deck range is a high quality, height adjustable platform designed specifically for upright microscopes widely used in electrophysiology and neuroscience, including the Nikon FN1/Ni, the Olympus BX51WI / BX61WI, and the Zeiss Axio Examiner microscopes.
QR Pharma, Inc. (QR) and Massachusetts General Hospital announced today a new collaborative research agreement to work on a treatment for Parkinson's disease (PD).
The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.
› Verified 2 days ago
| Entity Name | Pratt Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275570319 PECOS PAC ID: 3375515661 Enrollment ID: O20040807000255 |
News Archive
Children whose parents and families are under ongoing stress have more fevers with illness than other children. Published this month in the Archives of Pediatric and Adolescent Medicine, the study also shows the unanticipated conclusion that children's natural killer cell function, part of the body's innate immune system, increases under chronic stress, unlike adults, whose function is decreased.
Associate Professor Emeritus of Psychiatry and Pediatrics (OHSU, Portland, Oregon) is seeking roughly 50-100 volunteer families to participate in a vitamin D study. The goal of the study is to find out whether giving Vitamin D to the pregnant mother, who already has had at least one previous child with autism, can prevent the recurrence of autism in the newborn sibling.
Prior Scientific's Z-Deck range is a high quality, height adjustable platform designed specifically for upright microscopes widely used in electrophysiology and neuroscience, including the Nikon FN1/Ni, the Olympus BX51WI / BX61WI, and the Zeiss Axio Examiner microscopes.
QR Pharma, Inc. (QR) and Massachusetts General Hospital announced today a new collaborative research agreement to work on a treatment for Parkinson's disease (PD).
The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sucharita R Kher, MD 800 Washington St, Box 369, Boston, MA 02111-1552 Ph: (617) 636-6366 | Dr Sucharita R Kher, MD 800 Washington St, Box 369, Boston, MA 02111-1552 Ph: (617) 636-6366 |
News Archive
Children whose parents and families are under ongoing stress have more fevers with illness than other children. Published this month in the Archives of Pediatric and Adolescent Medicine, the study also shows the unanticipated conclusion that children's natural killer cell function, part of the body's innate immune system, increases under chronic stress, unlike adults, whose function is decreased.
Associate Professor Emeritus of Psychiatry and Pediatrics (OHSU, Portland, Oregon) is seeking roughly 50-100 volunteer families to participate in a vitamin D study. The goal of the study is to find out whether giving Vitamin D to the pregnant mother, who already has had at least one previous child with autism, can prevent the recurrence of autism in the newborn sibling.
Prior Scientific's Z-Deck range is a high quality, height adjustable platform designed specifically for upright microscopes widely used in electrophysiology and neuroscience, including the Nikon FN1/Ni, the Olympus BX51WI / BX61WI, and the Zeiss Axio Examiner microscopes.
QR Pharma, Inc. (QR) and Massachusetts General Hospital announced today a new collaborative research agreement to work on a treatment for Parkinson's disease (PD).
The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.
› Verified 2 days ago
Kaitlyn My-tu Lam, MBBS Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738 | |
Kui Toh Gerard Leong, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862 | |
Ruma Rajbhandari, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841 | |
Alaka Ray, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066 | |
Meghan E Sise, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862 | |
Aaron Dickstein, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292 | |
Dr. Felicia Elizabeth Patch, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676 |